Efficacy and safety of new oral anticoagulants compared with warfarin in cardioembolic prophylaxis of patients with non valvular atrial fibrillation. More lights than shadows
Submitted: 23 October 2012
Accepted: 23 October 2012
Published: 23 October 2012
Accepted: 23 October 2012
Abstract Views: 1623
PDF: 1921
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Tommaso Sacquegna, Anna Zaniboni, Andrea Rubboli, Gaetano Procaccianti, Michela Crisci, Fabiola Maioli, Giorgia Arnone, Giuseppe Di Pasquale, Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation , Italian Journal of Medicine: Vol. 9 No. 4 (2015)
- Luca Masotti, Rinaldo Innocenti, Stefano Spolveri, Irene Chiti, Grazia Panigada, Cristiana Seravalle, Giancarlo Landini, Alberto Fortini, Rino Migliacci, Raffaele Laureano, for Tuscan FADOI Stroke Registry Investigators, Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry , Italian Journal of Medicine: Vol. 9 No. 2 (2015)
- Michele Stornello, Roberto Cappellani, Giuseppe Micieli, Simona Sacco, Stefano Spolveri, Roberto Sterzi, Danilo Toni, Antonio Carolei, Cryptogenic stroke , Italian Journal of Medicine: Vol. 10 No. 3 (2016)
- Marco Masina, Cryptogenic strokes and embolic strokes of unknown source: lights and shadows of a new construct , Italian Journal of Medicine: Vol. 10 No. 3 (2016)
- Mosaad O. Almegren, Assessment and predictors of inappropriate dose of direct oral anticoagulants , Italian Journal of Medicine: Vol. 18 No. 1 (2024)
- Tiziana Ciarambino, Miriam Gino, Paola Gnerre, Elena Barbagelata, Nunzia Barone, Francesca Saladini, Federica Lorenzi, Marta Zanon, Maria Cristina Pasquini, Cecilia Politi, Young FADOI and gender medicine: sex gender differences in cardiovascular disease , Italian Journal of Medicine: Vol. 12 No. 1 (2018)
- Luca Masotti, Mario Di Napoli, Walter Ageno, Davide Imberti, Cecilia Becattini, Maurizio Paciaroni, Daniel Augustin Godoy, Roberto Cappelli, Giancarlo Landini, Grazia Panigada, Ido Iori, Domenico Prisco, Giancarlo Agnelli, Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation , Italian Journal of Medicine: Vol. 7 No. s8 (2013): The new oral anticoagulants in the Internal Medicine clinical practice
- Manuel Monti, Giovanni Maria Vincentelli, Francesco Borgognoni, Giuseppe Murdolo, Feliciano Menghini, A dangerous adverse event in the use of dabigatran , Italian Journal of Medicine: Vol. 10 No. 3 (2016)
- Mauro Silingardi, New anticoagulant drugs versus warfarin in atrial fibrillation: economic evaluation and cost-effectiveness analysis , Italian Journal of Medicine: Vol. 7 No. s8 (2013): The new oral anticoagulants in the Internal Medicine clinical practice
You may also start an advanced similarity search for this article.